References
-
1) Cytokeratin 13 promotes radiotherapy sensitivity of nasopharyngeal carcinoma by downregulating the MEK/ERK pathway.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: IUBMB LIFEImpactFactor: 4.6DOI: 10.1002/iub.2617PMID: 35426961 -
2) Metformin protects against pericyte apoptosis and promotes neurogenesis through suppressing JNK p38 MAPK signalling activation in ischemia/reperfusion injury.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: NEUROSCI LETTImpactFactor: 2.5DOI: 10.1016/j.neulet.2022.136708PMID: 35660649 -
3) Periostin aggravates the early phase of traumatic brain injury via the MAPK/ERK pathway.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: NEUROL RESImpactFactor: 1.9DOI: 10.1080/01616412.2021.2024728PMID: 35001858 -
4) Timosaponin B-II alleviates osteoarthritis-related inflammation and extracellular matrix degradation through inhibition of mitogen-activated protein kinases and nuclear factor-κB pathways in vitro.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: BIOENGINEEREDImpactFactor: 4.9DOI: 10.1080/21655979.2021.2024685PMID: 35094658 -
5) CTRP3 alleviates cardiac ischemia/reperfusion injury via LAMP1/JIP2/JNK signaling pathway.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: ImagingImpactFactor: 0.4DOI: 10.18632/aging.203876PMID: 35114641 -
6) Pancreastatin inhibitor PSTi8 prevents free fatty acid-induced oxidative stress and insulin resistance by modulating JNK pathway: In vitro and in vivo findings.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: LIFE SCIImpactFactor: 6.1DOI: 10.1016/j.lfs.2021.120221PMID: 34902437 -
7) Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: Front PharmacolImpactFactor: 5.6DOI: 10.3389/fphar.2022.1015693PMID: 36210855 -
8) Processed product (Pinelliae Rhizoma Praeparatum) of Pinellia ternata (Thunb.) Breit. Alleviates the allergic airway inflammation of cold phlegm via regulation of PKC/EGFR/MAPK/PI3K-AKT signaling pathway.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: J ETHNOPHARMACOLImpactFactor: 5.4DOI: 10.1016/j.jep.2022.115449PMID: 35688257 -
9) Downregulation of the Long Noncoding RNA IALNCR Targeting MAPK8/JNK1 Promotes Apoptosis and Antagonizes Bovine Viral Diarrhea Virus Replication in Host Cells.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: J VIROLImpactFactor: 5.4DOI: 10.1128/jvi.01113-22PMID: 35993735 -
10) Advanced oxidation protein products induce annulus fibrosus cell senescence through a NOX4-dependent, MAPK-mediated pathway and accelerate intervertebral disc degeneration.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: PEERJImpactFactor: 2.7DOI: 10.7717/peerj.13826PMID: 35935259 -
11) Ganoderma lucidum polysaccharide ameliorated diabetes mellitus-induced erectile dysfunction in rats by regulating fibrosis and the NOS/ERK/JNK pathway.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: TRANSL ANDROL UROLImpactFactor: 2DOI: 10.21037/tau-22-428PMID: 35958898 -
12) Guang Chen Pi (the pericarp of Citrus reticulata Blanco's cultivars 'Chachi') inhibits macrophage-derived foam cell formation.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: J ETHNOPHARMACOLImpactFactor: 5.4DOI: 10.1016/j.jep.2022.115328PMID: 35489660 -
13) FGFR2 Mutation p.Cys342Arg Enhances Mitochondrial Metabolism-Mediated Osteogenesis via FGF/FGFR-AMPK-Erk1/2 Axis in Crouzon Syndrome.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: CELLS-BASELImpactFactor: 6DOI: 10.3390/cells11193129PMID: 36231091 -
14) Protective Effects of Oxyberberine in 5-Fluorouracil-Induced Intestinal Mucositis in the Mice Model.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: EVID-BASED COMPL ALTDOI: 10.1155/2022/1238358PMID: 35677366 -
15) Heat shock protein 20 suppresses breast carcinogenesis by inhibiting the MAPK and AKT signaling pathways.
Product: JNK1/2/3 Antibody (#AF6318)Year: 2022Journal: ONCOL LETTImpactFactor: 2.9DOI: 10.3892/ol.2022.13582PMID: 36380873